These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 19875543)

  • 41. Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
    Meneilly GS; Ryan EA; Radziuk J; Lau DC; Yale JF; Morais J; Chiasson JL; Rabasa-Lhoret R; Maheux P; Tessier D; Wolever T; Josse RG; Elahi D
    Diabetes Care; 2000 Aug; 23(8):1162-7. PubMed ID: 10937515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
    RISE Consortium
    Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes.
    Aslam M; Aggarwal S; Sharma KK; Galav V; Madhu SV
    PLoS One; 2016; 11(1):e0145730. PubMed ID: 26808523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin deficiency vs insulin resistance in NIDDM: concluding remarks by a 'biased' observer.
    Cerasi E
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S161-4. PubMed ID: 8894502
    [No Abstract]   [Full Text] [Related]  

  • 45. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
    Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
    Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 47. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study.
    Wang T; Lu J; Shi L; Chen G; Xu M; Xu Y; Su Q; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Zhao Z; Chen Y; Yan L; Qin G; Wan Q; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Lai S; Bi Y; DeFronzo RA; Wang W; Ning G;
    Lancet Diabetes Endocrinol; 2020 Feb; 8(2):115-124. PubMed ID: 31879247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
    Chen X; Maldonado E; DeFronzo RA; Tripathy D
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1398-1409. PubMed ID: 33524152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspects of the pathogenesis of type 2 diabetes.
    Efendić S; Luft R; Wajngot A
    Endocr Rev; 1984; 5(3):395-410. PubMed ID: 6381035
    [No Abstract]   [Full Text] [Related]  

  • 51. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
    Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B
    J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-prandial hyperglycaemia--the necessity for better control.
    Del Prato S
    Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
    [No Abstract]   [Full Text] [Related]  

  • 53. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
    Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
    Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
    Bunck MC; Diamant M; Cornér A; Eliasson B; Malloy JL; Shaginian RM; Deng W; Kendall DM; Taskinen MR; Smith U; Yki-Järvinen H; Heine RJ
    Diabetes Care; 2009 May; 32(5):762-8. PubMed ID: 19196887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of glucose removal rate and first phase insulin secretion in the offspring of two parents with non-insulin-dependent diabetes.
    Warram JH; Martin BC; Soeldner JS; Krolewski AS
    Adv Exp Med Biol; 1988; 246():175-9. PubMed ID: 3074649
    [No Abstract]   [Full Text] [Related]  

  • 56. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.
    Chen HS; Wu TE; Jap TS; Hsiao LC; Lee SH; Lin HD
    Diabetes Care; 2008 Oct; 31(10):1927-32. PubMed ID: 18556343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Target for glycemic control: concentrating on glucose.
    Monnier L; Colette C
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S199-204. PubMed ID: 19875552
    [No Abstract]   [Full Text] [Related]  

  • 59. A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
    Gastaldelli A; Balas B; Ratner R; Rosenstock J; Charbonnel B; Bolli GB; Boldrin M; Balena R
    Diabetes Obes Metab; 2014 Feb; 16(2):170-8. PubMed ID: 23911196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
    Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
    Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.